Neogen Chemicals Raises ₹600 Crore via QIP at ₹2,255/Share
Neogen Chemicals Limited raised approximately ₹600 crore through a Qualified Institutions Placement (QIP). The company allotted 26,60,753 equity shares at ₹2,255 per share. The QIP opened on September 10, 2026, and closed on September 16, 2026.
The QIP raised a substantial amount of approximately ₹600 crore, which is a material event for the company. This infusion of capital can significantly impact its financial structure, growth prospects, and operational capabilities.
The company successfully raised a significant amount of capital through a QIP, which is generally viewed positively as it strengthens the company's financial position and provides funds for growth or other strategic initiatives.
Neogen Chemicals Limited has successfully completed a Qualified Institutions Placement (QIP), raising approximately ₹599.99 crore (₹600 crore). The Fund-Raising Committee of the Company, in its meeting held on September 16, 2026, approved the issue and allotment of 26,60,753 Equity Shares at an issue price of ₹2,255 per share, including a premium of ₹2,245 per share. This issue price is higher than the determined floor price of ₹2,189.73.
The QIP, which opened on September 10, 2026, and closed on September 16, 2026, was undertaken following the approval of the Board of Directors on July 24, 2026, and a special resolution passed by shareholders on August 21, 2026.
Following this allotment, the company's paid-up equity share capital has increased from ₹27.38 crore (2,73,81,674 Equity Shares of ₹10 each) to ₹30.04 crore (3,00,42,427 Equity Shares of ₹10 each). The newly allotted equity shares will be listed on both BSE Limited and the National Stock Exchange of India Limited and will rank pari passu with the existing equity shares in all respects, including dividend payments and voting rights.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.